Cms-10434 #26 Aqm2017-ssd

Medicaid and CHIP Program (MACPro) (CMS-10434)

QSSI-MACPro-PRA-AQM2017-SSD

GenIC #26 (Transfer from 0938-1148) - Medicaid Adult and Child Core Set Measures

OMB: 0938-1188

Document [pdf]
Download: pdf | pdf
Centers for Medicare & Medicaid Services
CMS eXpedited Life Cycle (XLC)

Medicaid and CHIP Program (MACPro)
AQM 2017 – Diabetes Screening for People with
Schizophrenia or Bipolar Disorder Who Are Using
Antipsychotic Medications (SSD) Core Measure
PRA document
Version 1.0
08/29/2017

Document Number: 290-QSSI-MACPro-PRA-AQM2017-SSD-D
Contract Number: HHSM-500-2007-00024I: HHSM-500-T0014

CMS XLC

Table of Contents

Table of Contents
1. (SSD) Core Measure – Screenshots ....................................................................... 1
1.1
1.2
1.3
1.4
1.5
1.6
1.7

Are you reporting on this measure? ................................................................ 1
Measurement Specification – Path 1 ............................................................... 1
Measurement Specification – Path 2 ............................................................... 1
Data Source .................................................................................................... 2
Performance Measure ..................................................................................... 2
Deviations from Measurement Specifications ................................................. 2
Optional Measure Stratification ....................................................................... 2

Appendix A:

Acronyms ......................................................................................... 4

List of Figures
Figure 1: Are you reporting on this measure ................................................................... 1
Figure 2: Measurement Specification – 1 ........................................................................ 1
Figure 3: Measurement Specification – 2 ........................................................................ 1
Figure 4: Data Source ..................................................................................................... 2
Figure 5: Performance Measure ...................................................................................... 2
Figure 6: Deviations from Measurement Specifications .................................................. 2
Figure 7: Optional Measure Stratification – 1 .................................................................. 3
Figure 8: Optional Measure Stratification – 2 .................................................................. 3

List of Tables
Table 1: Acronyms .......................................................................................................... 4

AQM 2017 – Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD) Core
Measure PRA document
Version 1.0
i
08/29/2017

CMS XLC
(SSD) Core Measure – Screenshots

1. (SSD) Core Measure – Screenshots
1.1

Are you reporting on this measure?

Figure 1: Are you reporting on this measure?

1.2

Measurement Specification – Path 1

Figure 2: Measurement Specification – 1

1.3

Measurement Specification – Path 2

Figure 3: Measurement Specification – 2

AQM 2017 – Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD) Core
Measure PRA document
Version 1.0
1
08/29/2017

CMS XLC
(SSD) Core Measure – Screenshots

1.4

Data Source

Figure 4: Data Source

1.5

Performance Measure

Figure 5: Performance Measure

1.6

Deviations from Measurement Specifications

Figure 6: Deviations from Measurement Specifications

1.7

Optional Measure Stratification

Note: Same N/D/R sets are displayed under each of the stratification categories
AQM 2017 – Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD) Core
Measure PRA document
Version 1.0
2
08/29/2017

CMS XLC
(SSD) Core Measure – Screenshots

Figure 7: Optional Measure Stratification – 1

Figure 8: Optional Measure Stratification – 2

AQM 2017 – Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD) Core
Measure PRA document
Version 1.0
3
08/29/2017

CMS XLC
(SSD) Core Measure – Screenshots

Appendix A: Acronyms
Table 1: Acronyms
Acronym

Literal Translation

AQM

Adult Quality Measure

PRA

Paper Reduction Act of 1995

SDD

Diabetes Screening for People with Schizophrenia or Bipolar
Disorder Who Are Using Antipsychotic Medications

AQM 2017 – Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD) Core
Measure PRA document
Version 1.0
4
08/29/2017


File Typeapplication/pdf
File Modified2017-09-08
File Created2017-09-08

© 2024 OMB.report | Privacy Policy